Chau N P, Pithois-Merli I, Levenson J, Simon A C
Unité de Recherches Biomathématiques et Biostatistiques, INSERM U263, Université de Paris, France.
Eur J Clin Pharmacol. 1989;37(3):215-20. doi: 10.1007/BF00679772.
The effects of ketanserin (40 mg p.o.) on blood pressure and brachial haemodynamics (brachial artery diameter, brachial blood velocity and blood flow) have been compared in a double-blind study with those of ritanserin (10 mg p.o.) and placebo. Haemodynamic parameters were measured before and 1 h after treatment. Patients with mild to moderate essential hypertension participated in this study, 6 each on ketanserin, ritanserin and placebo. Placebo significantly reduced heart rate and did not modify the other parameters. Compared to placebo, ketanserin significantly reduced systolic and diastolic blood pressure, increased brachial blood velocity and flow, and decreased forearm vascular resistance. Compared to placebo, ritanserin slightly decreased blood pressure and slightly increased blood flow, but neither effect was significant. When blood circulation to the hand was excluded, neither ketanserin nor ritanserin modified the proximal arterial resistance or blood flow. It is concluded that the actions of ketanserin and ritanserin essentially occurred in the distal part of the upper limb, and alpha 1-receptor blockade is probably involved.
在一项双盲研究中,比较了酮色林(口服40毫克)与利坦色林(口服10毫克)及安慰剂对血压和肱动脉血流动力学(肱动脉直径、肱动脉血流速度和血流量)的影响。在治疗前及治疗后1小时测量血流动力学参数。轻度至中度原发性高血压患者参与了本研究,每组6人分别服用酮色林、利坦色林和安慰剂。安慰剂显著降低心率,但未改变其他参数。与安慰剂相比,酮色林显著降低收缩压和舒张压,增加肱动脉血流速度和血流量,并降低前臂血管阻力。与安慰剂相比,利坦色林使血压略有下降,血流量略有增加,但两种作用均不显著。当排除手部血液循环时,酮色林和利坦色林均未改变近端动脉阻力或血流量。得出的结论是,酮色林和利坦色林的作用主要发生在上肢远端,可能涉及α1受体阻断。